體外受精 (IVF) 市場規模、佔有率和成長分析：按週期、按程序、按最終用途、按地區 - 行業預測，2024-2031 年

2022 年，全球體外受精 (IVF) 市場規模將達到 242 億美元，從 2023 年的 260.9 億美元增至 2031 年的 475.4 億美元，預計在預測期內（2024-2031 年）將成長。率為7.79%。

全球體外受精（IVF）市場包括輔助生殖技術（ART）領域，其中卵子受精在人類體外進行。體外受精（IVF）已成為解決不孕症和幫助夫妻懷孕的一種有前景的方法。這個過程通常涉及卵巢刺激、取卵、受精和胚胎移植。體外受精（IVF）市場的主要目標是為患有不孕症的夫妻提供一種解決方案，在自然方法不足或不太可能成功時提供一條成功懷孕的途徑。全球不孕率上升是由於生活方式改變、延遲分娩、荷爾蒙異常和醫療狀況等因素造成的，這些因素推動了對體外受精 (IVF) 的需求。體外受精 (IVF) 的技術進步——包括改進的實驗室技術、改進的冷凍保存方法和先進的基因檢測——顯著提高了成功率。這些進步吸引了尋求可靠生育治療方法的夫妻。然而，治療的複雜性、成功率的不確定性和心理壓力等挑戰可能會阻礙體外受精 (IVF)。隨著人們意識的提高和不孕症治療的普及，體外受精 (IVF) 的需求不斷成長，尤其是在新興市場，這推動了市場的擴張。這為這些地區建立體外受精（IVF）診所和加強服務創造了機會。持續的技術創新和新興市場不斷成長的需求為體外受精 (IVF) 行業帶來了巨大的成長機會，並有望提高成功率並改善患者體驗。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 市場成功因素
• 競爭程度
• 主要投資機會
• 市場吸引力指數
• 生態系繪圖
• 價格分析
• 價值鏈分析

體外受精 (IVF) 市場：依週期

• 新鮮的非捐贈者
• 冷凍非捐贈者
• 新的捐贈者
• 冷凍供體

體外受精 (IVF) 市場：依最終用途分類

• 生育診所/體外受精 (IVF) 中心
• 手術中心
• 醫院
• 研究所
• 冷凍銀行

體外受精 (IVF) 市場：依治療方式

• 傳統體外受精（IVF）
• 體外受精 (IVF)/顯微授精
• 最小體外受精（IVF）
• 使用捐贈卵子進行體外受精 (IVF)
• 其他

體外受精 (IVF) 市場：依產品

• 裝置
  • 影像系統
  • 精子分離系統
  • 抽卵子泵
  • 顯微作業系統
  • 培養箱
  • 延時培養箱
  • 其他培養箱
  • 氣體分析儀
  • 雷射系統
  • 冷凍系統
  • 內閣
  • 防震台
  • 見證系統
  • 配件
• 試劑/介質
  • 胚胎培養基
  • 冷凍保存介質
  • 精子處理培養基
  • 卵子處理培養基

體外受精 (IVF) 市場規模：按地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Vitrolife AB (Sweden)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• Cook Medical (US)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• Merck KGaA (Germany)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• Thermo Fisher Scientific, Inc. (US)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• Esco Micro Pte Ltd (Singapore)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• Genea Limited (Australia)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• Ferring Pharmaceuticals (Switzerland)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• Hamilton Thorne, Inc. (Canada)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• Nidacon International AB (Sweden)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• Rocket Medical plc (UK)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• EMD Serono (US)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• Kitazato Corporation (Japan)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• IVFtech Aps (Denmark)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• Zeiss Group (Germany)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• Labotect GmbH (Germany)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• Esco Medical (Singapore)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• The Baker Company, Inc. (US)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• Boston IVF (US)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• Invitrocare Fertility Laboratories Pvt. Ltd. (India)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• EMD Serono, Inc. (US)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢
• Fujifilm Holdings Corporation (Japan)
  • 公司簡介
  • 事業部概況
  • 財務更新
  • 主要趨勢

Global In Vitro Fertilization Market size was valued at USD 24.20 Billion in 2022 and is poised to grow from USD 26.09 Billion in 2023 to USD 47.54 Billion by 2031, at a CAGR of 7.79% during the forecast period (2024- 2031).

The global in vitro fertilization (IVF) market encompasses the field of assisted reproductive technology (ART), where egg fertilization occurs outside the human body. IVF has become a prominent method for addressing infertility and helping couples achieve pregnancy. The process typically includes ovarian stimulation, egg retrieval, fertilization, and embryo transfer. The primary aim of the IVF market is to provide solutions for couples struggling with fertility issues, offering them a pathway to successful conception when natural methods are insufficient or unlikely to succeed. Increasing global infertility rates, driven by factors such as lifestyle changes, delayed childbearing, hormonal disorders, and medical conditions, have intensified the demand for IVF. Technological advancements in IVF-such as enhanced laboratory techniques, improved cryopreservation methods, and advanced genetic testing-have significantly boosted success rates. These improvements have attracted couples seeking reliable fertility solutions. However, challenges such as the complexity of treatment, uncertainties about success rates, and emotional stress can deter some individuals from pursuing IVF. The demand for IVF is growing particularly in developing regions, where increased awareness and better access to fertility treatments are facilitating market expansion. This presents opportunities for establishing IVF clinics and enhancing services in these areas. The ongoing technological innovations and rising demand from emerging markets represent significant growth opportunities for the IVF industry, promising improved success rates and better patient experiences.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global In Vitro Fertilization market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global In Vitro Fertilization Market Segmental Analysis

The global in vitro fertilization market is segmented based on cycle, end-user, procedure, product, and region. Based on cycle, the market is segmented into Fresh Donor, Fresh Non-Donor, Frozen Donor, Frozen Non-Donor. In terms of end-user, the market is segmented into Fertility Clinics & IVF Centers, Surgical Centers, Hospitals, Research Institutes, Cryobanks. Based on procedure, the market is segmented into Conventional IVF, IVF with ICSI, Minimal IVF, IVF with Donar Eggs, Others. Based on product, the market is segmented into Equipment (Microscopes, Sperm Analyzer Systems, Imaging Systems, Ovum Aspiration Pumps, Micromanipulator Systems, Incubators {Time-lapse incubators, Other incubators}, Gas Analyzers, Laser Systems, Cryosystems, Sperm Separation Devices, IVF Cabinets, Anti-vibration Tables, Witness Systems), Reagents & Media (Cryopreservation Media, Embryo Culture Media, Ovum Processing Media, Sperm Processing Media), Accessories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global In Vitro Fertilization Market

Rising awareness about infertility and the accessibility of IVF treatments have led to greater acceptance and demand for IVF procedures. As more individuals learn about these options, the stigma surrounding infertility has diminished. Public figures and celebrities who openly discuss their IVF experiences have played a crucial role in normalizing the procedure. Their stories have helped break down barriers, making IVF a more accepted and considered choice for those facing fertility challenges.

Restraints in the Global In Vitro Fertilization Market

IVF procedures raise several ethical and legal issues, including the use of donor gametes, embryo storage, and embryo selection. These concerns introduce regulatory complexities and result in differing IVF practices across various countries and regions. These variations can affect the growth and standardization of the IVF market, as different jurisdictions implement their own regulations and guidelines, leading to inconsistent practices and market dynamics.

Market Trends of the Global In Vitro Fertilization Market

In 2023, personalized medicine emerged as a significant trend in the IVF market. This approach focuses on customizing IVF treatment protocols according to individual patient factors, such as age, ovarian reserve, and specific fertility issues. The goal of personalized medicine is to enhance treatment outcomes and increase the efficiency of IVF procedures by tailoring interventions to meet the unique needs of each patient. This method aims to improve the overall effectiveness and success rates of IVF treatments.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors of The Market
• Degree Of Competition
• Top Investment Pockets
• Market Attractive Index
• Ecosystem Mapping
• Pricing Analysis
• Value Chain Analysis

In-Vitro Fertilization Market by Cycle

• Fresh Non-Donor
• Frozen Non-Donor
• Fresh Donor
• Frozen Donor

In-Vitro Fertilization Market by End Use

• Fertility Clinics & IVF Centers
• Surgical Centers
• Hospitals
• Research Institutes
• Cryobanks

In-Vitro Fertilization Market by Procedure

• Conventional IVF
• IVF with ICSI
• Minimal IVF
• IVF with Donor Eggs
• Others

In-Vitro Fertilization Market by Product

• Equipment
  • Imaging Systems
  • Sperm Separation System
  • Ovum Aspiration Pumps
  • Micromanipulator System
  • Incubators
  • Time-lapse incubators
  • Other incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Cabinets
  • Antivibration Tables
  • Witness Systems
  • Accessories
• Reagents and Media
  • Embryo Culture Media
  • Cryopreservation Media
  • Sperm Processing Media
  • Ovum Processing Media

In-Vitro Fertilization Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profile

• Vitrolife AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esco Micro Pte Ltd (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genea Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Thorne, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nidacon International AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rocket Medical plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EMD Serono (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kitazato Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IVFtech Aps (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zeiss Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labotect GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esco Medical (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Baker Company, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston IVF (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invitrocare Fertility Laboratories Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EMD Serono, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments